Presented here is a unified description of techniques that can be used to develop, transform, administer, and test heterologous protein expression of the probiotic yeast Saccharomyces boulardii.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
Presented here is a unified description of techniques that can be used to develop, transform, administer, and test heterologous protein expression of the probiotic yeast Saccharomyces boulardii.
Development of recombinant oral therapy would allow for more direct targeting of the mucosal immune system and improve the ability to combat gastrointestinal disorders. Adapting probiotic yeast in particular for this approach carries several advantages. These strains have not only the potential to synthesize a wide variety of complex heterologous proteins but are also capable of surviving and protecting those proteins during transit through the intestine. Critically, however, this approach requires expertise in many diverse laboratory techniques not typically used in tandem. Furthermore, although individual protocols for yeast transformation are well characterized for commonly used laboratory strains, emphasis is placed here on alternative approaches and the importance of optimizing transformation for less well characterized probiotic strains. Detailing these methods will help facilitate discussion as to the best approaches for testing probiotic yeast as oral drug delivery vehicles and indeed serve to advance the development of this novel strategy for gastrointestinal therapy.
Probiotic microorganisms are an intriguing potential means of efficiently and economically delivering heterologous proteins to the gastrointestinal tract. These organisms are capable of surviving passage through the gastrointestinal tract yet do not colonize it1, enabling controlled dosing and limiting exposure to the drug expressed. Furthermore, the ability to easily engineer these organisms to produce heterologous protein on a large scale renders them an economical alternative to synthetic delivery particles. However, development of such an approach, as recently demonstrated using an auxotrophic strain of the probiotic yeast Saccharomyces bou....
Access restricted. Please log in or start a trial to view this content.
1. UV Mutagenesis to Generate Auxotrophic Yeast Strains
Access restricted. Please log in or start a trial to view this content.
Generation of a survival curve following UV irradiation requires plating of diluted yeast cells such that distinct colony forming units (CFU) are able to form. Each 500 µl sample collected as described above contains approximately 5 x 106 cells; however, greater than 100 colonies per plate are difficult to accurately distinguish. Plating undiluted sample as well as serial 1:10 dilutions of irradiated cells thus ensures that CFU can be enumerated at each UV dose, as demonstrated.......
Access restricted. Please log in or start a trial to view this content.
Together, the protocols herein describe the essential steps necessary for the development and testing of auxotrophic probiotic yeast strains for delivery of heterologous therapeutic protein to the intestine. This manipulation and testing of recombinant probiotic yeast requires techniques and resources with which any individual laboratory may not currently be familiar. Thus, although numerous previous studies have described the above protocols for multiple yeast and mouse strains, these methods have not to the authors'.......
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
The authors acknowledge funding through the Children's Center for Immunology and Vaccines and an NIH New Innovator Award (1DP2AI112242-01) awarded to Tracey J. Lamb. The authors also thank Natalya P. Degtyareva for the generous contribution of rad1 S. cerevisiae.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| SmartSpec 3000 Spectrophotometer | BioRad | 170-2501 | Example of spectrophotometer for determining cell concentration and OD600 of yeast cultures |
| New Brunswick Roller Drum | Eppendorf | M1053-4004 | Example of roller drum for yeast culture incubation |
| UV Stratalinker 2400 | Stratagene | 400075-03 | Example stratalinker |
| Stuart Colony Counter SC6PLUS | 11983044 | Fisher Scientific | Plate stand with magnification records colony count upon sensing pressure from pen |
| Scienceware Colony Counter | F378620002 | Bel-Art Scienceware | Hand held colony counter pen |
| Replica plating device | Fisherbrand | 09-718-1 | Example of replica plating stand and pads |
| Velveteen squares | Fisherbrand | 09-718-2 | |
| L shaped sterile cell spreaders | Fisherbrand | 14665230 | |
| Deoxyribonucleic acid, single stranded from salmon testes | Sigma-Aldrich | D7656-1ML | Example carrier DNA for yeast LiOAc transformation |
| Gavage needles | Braintree Scientific | N-PK 002 | For mice 15-20 g, the suggested needle is a 22 gauge (1.25 mm ball), 1 in long, straight reusable gavage needle. For mice weighing greater than 20 g, 20 gauge or larger straight or curved gavage needles may be used |
| 1 ml sterile slip-tip disposable tuberculin syringe | Becton Dickinson | BD 309659 | |
| Blunt forceps such as Electron Microscopy Sciences 7" (178 mm) serrated tip, broad grip forceps | Electron Microscopy Sciences | 77937-28 | Example of blunt forceps needed for dissection |
| Straight and curved dissection scissors | Electron Microscopy Sciences | 72966-02 and 72966-03 | Examples of scissors needed for dissection |
| IMDM | Life technologies | 12440053 |
Access restricted. Please log in or start a trial to view this content.